Procter & Gamble Health Limited (PGHL)
Healthcare | Drug Manufacturers - Specialty & Generic
₹5757.0
0.16%
Margin Metrics
| Gross Margin | 68.2% |
| Operating Margin | 24.7% |
| Net Margin | 17.8% |
Return Metrics
| Return on Equity (ROE) | 0.0% |
| Return on Assets (ROA) | 25.3% |
| Return on Invested Capital (ROIC) | 2189.7% |
Profitability Analysis Score: 70/100
Profitability Score: 70/100
Key Performance Indicators:
- Excellent cost management with gross margin above 40%
- Good operational efficiency with margin above 15%
- Good profitability with net margin above 10%
- Excellent capital efficiency with ROIC above 20%
Recommendation
Strong Profitability - Company shows robust financial performance with good margins
Detailed Analysis
Margin Analysis: Gross margin of 68.2% indicates exceptional cost management.
Operational Efficiency: Operating margin of 24.7% shows good operational control.
Bottom Line: Net margin of 17.8% demonstrates adequate overall profitability.
Risk Assessment Guide
- Score 80-100: Superior profitability with strong competitive advantages
- Score 60-79: Healthy profitability with good market position
- Score 40-59: Average profitability with improvement opportunities
- Score Below 40: Weak profitability requiring strategic intervention
Key Metrics
- Return on Equity: 0.0%
- Return on Invested Capital: 2189.7%
- Return on Assets: 25.3%
Last Updated: 03-Jun-2025 05:57 AM